senate Bill S6746A

2021-2022 Legislative Session

Relates to the availability of buprenorphine in opioid treatment programs

download bill text pdf

Sponsored By

Current Bill Status - Passed Senate


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

Your Voice

do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

view actions (10)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
May 25, 2022 referred to ways and means
delivered to assembly
passed senate
May 11, 2022 advanced to third reading
May 10, 2022 2nd report cal.
May 09, 2022 1st report cal.1092
Apr 27, 2022 print number 6746a
Apr 27, 2022 amend and recommit to alcoholism and substance abuse
Jan 05, 2022 referred to alcoholism and substance abuse
May 13, 2021 referred to alcoholism and substance abuse

Votes

view votes

May 9, 2022 - Alcoholism and Substance Abuse committee Vote

S6746A
5
0
committee
5
Aye
0
Nay
1
Aye with Reservations
0
Absent
1
Excused
0
Abstained
show Alcoholism and Substance Abuse committee vote details

Alcoholism and Substance Abuse Committee Vote: May 9, 2022

aye wr (1)
excused (1)

S6746 - Details

See Assembly Version of this Bill:
A705
Law Section:
Mental Hygiene Law
Laws Affected:
Add §32.12, Ment Hyg L
Versions Introduced in 2019-2020 Legislative Session:
A5953

S6746 - Summary

Requires facilities that provide treatment for substance use disorders to have at least one practitioner qualified to administer or prescribe buprenorphine to individuals in their care with substance use disorders related to opioids.

S6746 - Sponsor Memo

S6746 - Bill Text download pdf

 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   6746
 
                        2021-2022 Regular Sessions
 
                             I N  S E N A T E
 
                               May 13, 2021
                                ___________
 
 Introduced  by Sen. HARCKHAM -- read twice and ordered printed, and when
   printed to be committed to the Committee on Alcoholism  and  Substance
   Abuse
 
 AN  ACT to amend the mental hygiene law, in relation to the availability
   of buprenorphine in opioid treatment programs
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1.  The mental hygiene law is amended by adding a new section
 32.12 to read as follows:
 § 32.12 AVAILABILITY OF BUPRENORPHINE.
   EVERY  FACILITY  LICENSED  OR  AUTHORIZED  TO  PROVIDE  SERVICES   FOR
 SUBSTANCE  USE  DISORDERS  RELATED  TO  OPIOIDS THAT EMPLOYS A QUALIFIED
 PRACTITIONER, AS DETERMINED BY FEDERAL LAW, SHALL ENSURE  AT  LEAST  ONE
 PRACTITIONER  IN  THE FACILITY HAS RECEIVED AN APPROPRIATE WAIVER AND/OR
 HAS COMPLETED REQUIRED TRAINING TO ADMINISTER BUPRENORPHINE TO  INDIVID-
 UALS  IN  THEIR  CARE  WITH  A SUBSTANCE USE DISORDER WHERE SUCH DRUG IS
 DETERMINED APPROPRIATE FOR THEIR TREATMENT.
   § 2. This act shall take effect on the one hundred twentieth day after
 it shall have become a law.  Effective immediately, the addition, amend-
 ment and/or repeal of any rule or regulation necessary for the implemen-
 tation of this act on its effective date are authorized to be  made  and
 completed on or before such effective date.
 
 
 
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD00547-04-1


Co-Sponsors

S6746A (ACTIVE) - Details

See Assembly Version of this Bill:
A705
Law Section:
Mental Hygiene Law
Laws Affected:
Add §32.12, Ment Hyg L
Versions Introduced in 2019-2020 Legislative Session:
A5953

S6746A (ACTIVE) - Summary

Requires facilities that provide treatment for substance use disorders to have at least one practitioner qualified to administer or prescribe buprenorphine to individuals in their care with substance use disorders related to opioids.

S6746A (ACTIVE) - Sponsor Memo

S6746A (ACTIVE) - Bill Text download pdf

 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                  6746--A
 
                        2021-2022 Regular Sessions
 
                             I N  S E N A T E
 
                               May 13, 2021
                                ___________
 
 Introduced  by Sen. HARCKHAM -- read twice and ordered printed, and when
   printed to be committed to the Committee on Alcoholism  and  Substance
   Abuse  --  recommitted  to  the  Committee on Alcoholism and Substance
   Abuse  in  accordance  with  Senate  Rule  6,  sec.  8  --   committee
   discharged, bill amended, ordered reprinted as amended and recommitted
   to said committee
 
 AN  ACT to amend the mental hygiene law, in relation to the availability
   of buprenorphine in opioid treatment programs
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1.  The mental hygiene law is amended by adding a new section
 32.12 to read as follows:
 § 32.12 AVAILABILITY OF BUPRENORPHINE.
   EVERY  FACILITY  LICENSED  OR  AUTHORIZED  TO  PROVIDE  SERVICES   FOR
 SUBSTANCE  USE  DISORDERS  RELATED  TO  OPIOIDS THAT EMPLOYS A QUALIFIED
 PRACTITIONER, AS DETERMINED BY FEDERAL LAW, SHALL ENSURE  AT  LEAST  ONE
 PRACTITIONER  IN  THE FACILITY HAS RECEIVED AN APPROPRIATE WAIVER AND/OR
 HAS COMPLETED REQUIRED TRAINING TO ADMINISTER OR PRESCRIBE BUPRENORPHINE
 TO INDIVIDUALS IN THEIR CARE WITH A SUBSTANCE USE  DISORDER  WHERE  SUCH
 DRUG IS DETERMINED APPROPRIATE FOR THEIR TREATMENT.
   § 2. This act shall take effect on the one hundred twentieth day after
 it shall have become a law.  Effective immediately, the addition, amend-
 ment and/or repeal of any rule or regulation necessary for the implemen-
 tation  of  this act on its effective date are authorized to be made and
 completed on or before such effective date.
 
 
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD00547-05-2


Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.